ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Smokeless Tobacco Warning Bill May Go To House Floor

January 24, 1986

Women’s Health: Treatment to Move Toward Pre-Cancer, Klausner Says

December 5, 1997

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

July 29, 2011

Ominous Note: Magnuson Hints Senate May Cut NCI Budget 5% Under President’s 1980 Request

March 9, 1979

Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard

February 22, 2013

MammoSite Radiation System Delivers Dose To Target Tissue

February 28, 2003